Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome.

I B Van den Veyver1, H Y Zoghbi

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. iveyver@bcm.tmc.edu

Brain & Development
|December 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implication of chromosomal microarray analysis prior to in-utero repair of fetal open neural tube defect.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2023
Same author

No evidence for mutations in NLRP7, NLRP2 or KHDC3L in women with unexplained recurrent pregnancy loss or infertility.

Human reproduction (Oxford, England)·2014
Same author

A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles.

Molecular human reproduction·2007
Same author

Biparental hydatidiform moles: a maternal effect mutation affecting imprinting in the offspring.

Human reproduction update·2006
Same author

Tooth enamel defects in mice with a deletion at the Arhgap 6/Amel X locus.

Calcified tissue international·2005
Same author

The clinical and genetic spectrum of spinocerebellar ataxia 14.

Neurology·2005
Same journal

Association of relative age with medical consultations for developmental concerns: A nationwide birth cohort study in Japan.

Brain & development·2026
Same journal

Extending the combined N-back/Nogo paradigm: Toward subtype-sensitive and translationally meaningful ERP research in ADHD.

Brain & development·2026
Same journal

Receptor-specific dopaminergic imbalance and sensory gating in Lesch-Nyhan syndrome.

Brain & development·2026
Same journal

From weather stations to the home environment: Refining seizure prediction in pediatric drug-resistant epilepsy.

Brain & development·2026
Same journal

Pediatric GBS-myelitis overlap syndrome: Severe phenotype, treatment response, and neurological outcomes.

Brain & development·2026
Same journal

Aspartoacylase (ASPA) gene mutations and neuroimaging features in Iranian patients with Canavan disease: a descriptive study.

Brain & development·2026
See all related articles

Rett syndrome is caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene. Non-random X-chromosome inactivation may protect female carriers from severe symptoms.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Rett syndrome is a rare X-linked dominant neurodevelopmental disorder primarily affecting girls.
  • Approximately 80% of classic Rett syndrome cases are linked to mutations in the methyl-CpG-binding protein 2 (MECP2) gene.
  • MeCP2 plays a crucial role in linking DNA methylation to transcriptional repression, essential for normal brain development.

Purpose of the Study:

  • To investigate the functional consequences of MECP2 mutations in Rett syndrome.
  • To explore the relationship between X-chromosome inactivation (XCI) patterns and disease severity in female carriers.
  • To understand how different MECP2 mutations affect protein function and disease presentation.

Main Methods:

  • Analysis of MECP2 gene mutations in Rett syndrome patients.

Related Experiment Videos

  • Assessment of X-chromosome inactivation patterns in affected individuals and carriers.
  • Evaluation of mutant mRNA stability in patients with truncating mutations.

    • Main Results:

    • MECP2 mutations are the primary cause of Rett syndrome, leading to altered gene transcription during brain development.
    • While most patients exhibit random XCI, skewed patterns are observed in some, particularly in asymptomatic or mildly affected female carriers.
    • Non-random XCI patterns in some patients with truncating mutations suggest partial loss of MECP2 function and could attenuate disease effects.
    • Mutant mRNA stability was observed in patients with truncating mutations, supporting the possibility of partial loss of function.

    Conclusions:

    • MECP2 mutations disrupt normal brain development in Rett syndrome.
    • X-chromosome inactivation patterns significantly influence the clinical presentation and severity of Rett syndrome in female carriers.
    • Further research is needed to fully elucidate the functional impact of various MECP2 mutations and their correlation with XCI patterns in Rett syndrome.